Treatment of obsessive-compulsive disorder using clomipramine in a very old patient

被引:3
作者
Trappler, B [1 ]
机构
[1] SUNY Hlth Sci Ctr, Dept Psychiat, Brooklyn, NY 11203 USA
关键词
Alzheimer disease; obsessive-compulsive disorder; fluoxetine; clomipramine;
D O I
10.1345/aph.18193
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To describe the effect of the tricyclic drug clomipramine in a very old patient with obsessive-compulsive disorder and Alzheimer dementia. CASE SUMMARY: A 93-year-old woman had a history of obsessive-compulsive disorder since early adulthood. The obsession consisted of remembering names of famous people and the compulsion consisted of excessive list making. With the onset of memory loss secondary to Alzheimer disease, she became increasingly anxious and compulsive as a result of a failure to remember. After nine weeks on fluoxetine she became jittery and more confused. After a two-week wash-out period, she was given a nine-week course of clomipramine that was carefully titrated up to a therapeutic concentration. RESULTS: At the completion of clomipramine treatment, the patient no longer felt driven to recall the names of famous people. Her score from the Yale-Brown Obsessive-Compulsive Scale dropped from 29 to 3. Her Folstein Mini-Mental State Examination score increased from 21 to 23. CONCLUSIONS: Clomipramine appeared much more effective and better tolerated than fluoxetine in this very old patient despite its potential anticholinergic effect and the coexistence of Alzheimer disease.
引用
收藏
页码:686 / 690
页数:5
相关论文
共 50 条
  • [1] Personalized Medicine in the Treatment of a Patient With Obsessive-Compulsive Disorder With Clomipramine
    Preskorn, Sheldon H.
    Rode, Ryan
    JOURNAL OF PSYCHIATRIC PRACTICE, 2023, 29 (06) : 469 - 475
  • [2] COMPARISON OF CLOMIPRAMINE, ALPRAZOLAM AND PLACEBO IN THE TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER
    STEIN, DJ
    HOLLANDER, E
    MULLEN, LS
    DECARIA, CM
    LIEBOWITZ, MR
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1992, 7 (06) : 389 - 395
  • [3] Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder
    Karameh, Wael Karameh
    Khani, Munir
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 (02)
  • [4] TRAZODONE TREATMENT IN CLOMIPRAMINE-RESISTANT OBSESSIVE-COMPULSIVE DISORDER
    HERMESH, H
    AIZENBERG, D
    MUNITZ, H
    CLINICAL NEUROPHARMACOLOGY, 1990, 13 (04) : 322 - 328
  • [5] CLOMIPRAMINE VS FLUOXETINE IN OBSESSIVE-COMPULSIVE DISORDER - AN UNCONTROLLED STUDY
    ANANTH, J
    ELMISHAD, A
    WOHL, M
    ADVANCES IN THERAPY, 1993, 10 (06) : 288 - 292
  • [6] Clomipramine demethylation rate is important on the outcome of obsessive-compulsive disorder treatment
    Marcourakis, Tania
    Bernik, Marcio A.
    Lotufo Neto, Francisco
    Shavitt, Roseli Gedanke
    Gorenstein, Clarice
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (01) : 43 - 48
  • [7] A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder
    Milanfranchi, A
    Ravagli, S
    Lensi, F
    Marazziti, D
    Cassano, GB
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1997, 12 (03) : 131 - 136
  • [8] Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents
    De Haan, E
    Hoogduin, KAL
    Buitelaar, JK
    Keijsers, GPJ
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1998, 37 (10) : 1022 - 1029
  • [9] Plasma clomipramine levels in adult patients with obsessive-compulsive disorder
    Marazziti, Donatella
    Baroni, Stefano
    Faravelli, Luca
    Giannaccini, Gino
    Massimetti, Gabriele
    Palego, Lionella
    Catena-Dell'Osso, Mario
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (01) : 55 - 60
  • [10] Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder
    Mundo, E
    Maina, G
    Uslenghi, C
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2000, 15 (02) : 69 - 76